Alnylam Pharmaceuticals ALNY reported its Q3 earnings results on Thursday, October 27, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Alnylam Pharmaceuticals beat estimated earnings by 11.24%, reporting an EPS of $-1.58 versus an estimate of $-1.78.
Revenue was up $76.67 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.41 which was followed by a 1.03% drop in the share price the next day.
Here's a look at Alnylam Pharmaceuticals's past performance:
|Quarter||Q2 2022||Q1 2022||Q4 2021||Q3 2021|
To track all earnings releases for Alnylam Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.